/ /

  • Active context: modern_retina_specialist_domain_homepage
  • Active context: modern_retina_specialist_header_nav
  • Active context: common_blocks

Topical bevacizumab (Avastin) has shown excellent preliminary results and good topical tolerance when used in the prevention of corneal transplant failure.

Latest Tweets Follow

Poll

View Results

var script= ' ';